ENO1 and ovarian carcinoma: Finally, NTBC inhibited the development of ovarian cancer in A2780 CDX mouse model (Figure 6G,H; Figure S8B,C, Supporting Information) and reduced the protein levels of TPI and ENO1 (Figure 6I; Figure S8D, Supporting Information).